Last updated on February 2018

TriVascular Evaluation of Females Who Are Underrepresented Candidates for Abdominal Aortic Aneurysm Repair in Europe


Brief description of study

The LUCY Study is a prospective, consecutively enrolling, non-randomized multi center post-market study to evaluate the low profile (14F) Ovation Abdominal Stent Graft Platform when used in the endovascular treatment of female patients.

Detailed Study Description

The LUCY Study is a prospective, consecutively enrolling, non-randomized multi center post-market study to evaluate the Ovation Abdominal Platform when used in the endovascular treatment of female patients.

The primary endpoint is freedom from access-related vascular complications and freedom from AAA-related mortality through 30 days.

Secondary endpoints of the study will be achieved by demonstrating the benefits in female patients despite the fact that historically fewer female patients have been eligible for EVAR, and they have experienced a higher rate of access-related complications and higher mortality rates. Secondary endpoints will be evaluated through 1 year (365 60 days) post-procedure.

Clinical Study Identifier: NCT02703428

Contact Investigators or Research Sites near you

Start Over

Stepan Eder, MD

Schwarzwald-Baar Klinik
Villigen-Schwennigen, Germany
7.34miles
  Connect »